邁博藥業-B(02181.HK)將於3月26日舉行董事會會議以審批全年業績

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

邁博藥業-B(02181.HK)將於3月26日舉行董事會會議以審批全年業績

格隆匯 03-13 16:42

格隆匯3月13日丨邁博藥業-B(02181.HK)發佈公吿，公司董事會將於2024年3月26日舉行董事會會議，以考慮及批准公司及其附屬公司截至2023年12月31日止年度的全年業績及公吿。

邁博藥業-B(02181.HK)

Relevant Stocks

邁博藥業-B(02181.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

邁博藥業-B(02181.HK)將於3月26日舉行董事會會議以審批全年業績

Services

About Us

Agreement Statement